In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
Preclinical data demonstrate the activity of novel peptides, empirically designed with no reference to cytokine sequence or receptor structure, that mimic cytokine activity on heterodimeric cytokine receptors
- AMV564, a novel first-in-class agent that depletes MDSC and activates T cells, is being investigated in a Phase 1 clinical trial in advanced solid tumors